Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint inhibitors in pancreatic cancer. - Mahat DB; Kumra H; Castro SA; Metcalf E; Nguyen K; Morisue R; Ho WW; Chen I; Sullivan B; Yim LH; Singh A; Fu J; et al. (Immunity, 2025)